Latest week
10 Jul 2026
Close
0.072000
Fair value
0.421301
Next-week expectancy
Negative 27.72%
Sharemaestro

RGT Chart Pack

Argent BioPharma Limited

Exchange
ASX
Latest week
10 Jul 2026
Close
0.072000
Fair value
0.421301
Next-week expectancy
Negative 27.72%
Generated
17 Jul 2026 00:38
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, RGT rose 89.47%, moving from 0.04 to 0.07. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is 10.44 and has improved across the 12-week window. Market Dynamics is 1.11 on the latest week. Next-week expectancy is negative at 27.72% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
0.07
12-Week Change
89.47%
Trend Signal
Inactive
Next-Week Expectancy
Negative 27.72%
Signal Weeks
0 of 12
Vs Trend Line
Above
Vs Fair Value
Below
Relative Strength
10.44
Market Dynamics
1.11

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
0.07
12-Week Change
89.47%
Trend Signal
Inactive
Next-Week Expectancy
Negative 27.72%
Signal Weeks
0 of 12
Vs Trend Line
Above
Vs Fair Value
Below
Relative Strength
10.44
Market Dynamics
1.11

Over the latest 12 completed weeks ending 2026-07-10, RGT rose 89.47%, moving from 0.04 to 0.07. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is 10.44 and has improved across the 12-week window. Market Dynamics is 1.11 on the latest week. Next-week expectancy is negative at 27.72% based on similar historical setup states.

Industry Peers

Australia equities in Drug Manufacturers - Specialty & Generic

Stock Exchange Week Open High Low Close Change
IVX Invion Limited ASX 10 Jul 2026 0.03 0.04 0.03 0.04 15.62%
LGP Little Green Pharma Ltd ASX 10 Jul 2026 0.07 0.07 0.07 0.07 4.48%
IDT IDT Australia Limited ASX 10 Jul 2026 0.03 0.03 0.03 0.03 3.23%
AFP AFT Pharmaceuticals Limited ASX 10 Jul 2026 3.04 3.30 3.04 3.13 2.96%
VLS Vita Life Sciences Limited ASX 10 Jul 2026 2.48 2.50 2.40 2.50 0.81%
BP8 BPH Global Ltd ASX 10 Jul 2026 0.00 0.00 0.00 0.00 0.00%
ECS ECS Botanics Holdings Ltd ASX 10 Jul 2026 0.01 0.01 0.00 0.01 0.00%
EPN Epsilon Healthcare Limited ASX 10 Jul 2026 0.02 0.02 0.02 0.02 0.00%
EXL Elixinol Wellness Limited ASX 10 Jul 2026 0.01 0.01 0.01 0.01 0.00%
PER PERCHERON FPO [PER] ASX 10 Jul 2026 0.00 0.00 0.00 0.00 0.00%
VIT Vitura Health Limited ASX 10 Jul 2026 0.03 0.03 0.03 0.03 0.00%
MVP Medical Developments International Limited ASX 10 Jul 2026 0.42 0.44 0.41 0.41 -2.41%
PKP PEAK FPO [PKP] ASX 10 Jul 2026 0.02 0.02 0.02 0.02 -5.56%
SNT Syntara Limited ASX 10 Jul 2026 0.03 0.03 0.02 0.02 -8.00%
CAN Cann Group Limited ASX 10 Jul 2026 0.01 0.01 0.00 0.00 -10.00%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.